Avanos Medical, Inc. (NYSE:AVNS) SVP Kerr Holbrook Sells 7,000 Shares

Avanos Medical, Inc. (NYSE:AVNS) SVP Kerr Holbrook sold 7,000 shares of the business’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at approximately $1,251,216.75. This represents a 7.86 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Avanos Medical Price Performance

Avanos Medical stock opened at $14.93 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm has a market cap of $686.87 million, a P/E ratio of 43.91 and a beta of 1.17. The business’s fifty day moving average is $16.00 and its two-hundred day moving average is $19.24. Avanos Medical, Inc. has a 52 week low of $14.40 and a 52 week high of $25.36.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. The company had revenue of $179.60 million for the quarter, compared to analyst estimates of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Equities research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Avanos Medical

A number of institutional investors and hedge funds have recently bought and sold shares of AVNS. Quarry LP bought a new stake in shares of Avanos Medical during the third quarter worth $42,000. Quantbot Technologies LP bought a new stake in shares of Avanos Medical during the fourth quarter worth $64,000. KBC Group NV raised its position in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after acquiring an additional 1,095 shares during the last quarter. State of Wyoming raised its position in shares of Avanos Medical by 132.0% during the fourth quarter. State of Wyoming now owns 5,137 shares of the company’s stock worth $82,000 after acquiring an additional 2,923 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its position in shares of Avanos Medical by 493.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company’s stock worth $129,000 after acquiring an additional 6,714 shares during the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.